ARTICLE | Editor's Commentary
China biotech and the bear: a Perspective
Deal-making with the West offers a path through uncertain times, but in what position will China biotechs emerge from the bear?
November 8, 2024 11:43 PM UTC
Editor in Chief Simone Fishburn selected this story as one of BioCentury's Best of 2024. To see the full list, click here.
Welcome to Shanghai, where a raft of licensing deals centered on new modalities, a handful of high-profile takeouts and a new style of start-up has invigorated the local biotech industry...